Semaglutide is a medication initially used to treat type 2 diabetes but has recently shown significant benefits in weight loss
AnnualSave 47% Discounted annual rate Access to all articles (web + app) Ad-free exclusive newsletters Commenting Access Daily crossword Sneak peek of launches & events Monthly Access to all articles (web + app) Ad-free exclusive newsletters Commenting Access Daily crossword Sneak peek of launches & events Ad-Free Premium ad-free reading Access to all articles (web + app) Ad-free exclusive newsletters Commenting Access Daily crossword Sneak peek of launches & events Already have an account
Conclusion While combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists holds promise for addressing residual cardiovascular risk in type 2 diabetes, its optimal use requires nuanced consideration of patient subpopulations, safety, and cost-effectiveness
Archive of Oncology , 9 (3), 179-184
The copay also isnt eligible for the Medicare Prescription Payment Plan, which lets beneficiaries spread their out-of-pocket drug costs throughout the calendar year
The company's revenues declined by 10.8% year-over-year (YOY) to $172.09 million